GC2501 Study Site 500

Vigo

1 studies enrolling now · 1 studies all time

What they study most

Alpha 1 Antitrypsin Deficiency

Studies at this site

• A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD) — Recruiting now